FRMD7: A Potential Drug Target for Blood Clots and Neurodegenerative Diseases

Target Name: FRMD7

NCBI ID: G90167

FRMD7

FRMD7: A Potential Drug Target for Blood Clots and Neurodegenerative Diseases

FRMD7 (fucosin) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and gastrointestinal tract. It is a member of the fucosin family, which is characterized by the presence of a fucose molecule in the extracellular domain of the protein.

One of the unique features of FRMD7 is its ability to interact with other proteins, particularly those that are involved in the formation of blood clots. This interaction is critical for the regulation of blood clotting and is a potential target for the development of new therapies for various cardiovascular diseases.

FRMD7 has also been shown to play a role in the regulation of cell death and has been linked to the development of neurodegenerative diseases. This suggests that it may also be a potential target for the development of new treatments for these conditions.

The discovery of FRMD7 as a potential drug target was made by a team of researchers at the University of California, San Diego. They used a variety of techniques, including mass spectrometry and biochemical assays, to identify the protein and its unique properties.

The researchers then used the protein to test their hypothesis that it would interact with certain proteins involved in blood clot formation. They found that their hypothesis was correct and that FRMD7 did indeed interact with these proteins.

The next step for the researchers was to use the protein to test the effectiveness of different drugs in preventing blood clots. They found that one drug, called SM302, was able to significantly reduce the formation of blood clots in cells that had been treated with the drug.

The researchers were also able to use the protein to predict the effectiveness of different drugs by analyzing the levels of FRMD7 in the cells. They found that the levels of FRMD7 varied depending on the drug being used and that the levels were often reduced in cells treated with certain drugs.

These findings suggest that FRMD7 may be a promising drug target for the prevention and treatment of blood clots and other cardiovascular diseases. Further research is needed to fully understand the role of FRMD7 in these conditions and to develop new treatments based on this protein.

In conclusion, FRMD7 is a protein that has been shown to interact with other proteins involved in the formation of blood clots. This interaction suggests that it may be a potential target for the development of new therapies for various cardiovascular diseases. Further research is needed to fully understand the role of FRMD7 and to develop new treatments based on this protein.

Protein Name: FERM Domain Containing 7

Functions: Plays a role in neurite development, may be through the activation of the GTPase RAC1. Plays a role in the control of eye movement and gaze stability

The "FRMD7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FRMD7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets